Arcus Biosciences, Inc. (RCUS)
25.07
-0.73
(-2.83%)
USD |
NYSE |
Dec 09, 16:00
24.88
-0.19
(-0.76%)
Pre-Market: 07:55
Arcus Biosciences Market Cap: 3.102B for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Actinium Pharmaceuticals, Inc. | 44.61M |
| Apyx Medical Corp. | 155.64M |
| Gilead Sciences, Inc. | 148.09B |
| Merck & Co., Inc. | 240.48B |
| Karyopharm Therapeutics, Inc. | 108.96M |
Market Cap Related Metrics
| PS Ratio | 10.53 |
| PEG Ratio | -0.832 |
| Price to Book Value | 7.114 |
| Price | 25.07 |
| Earnings Yield | -13.69% |
| PEGY Ratio | -0.832 |